STOCK TITAN

Dalrada Technology Group (DHTI) 10-Q Filings

DHTI OTC

Here are the 10-Q quarterly reports from Dalrada Technology Group (DHTI) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-Q covers the quarterly report filed between annual reports, so if you follow DHTI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full DHTI filings page.

Rhea-AI Summary

Dalrada Technology Group, Inc. reported weak results for the quarter ended March 31, 2026, with total revenue of $2.6M, down from $4.6M in the prior-year quarter. Gross profit was $0.8M, while operating expenses of $4.1M drove a loss from operations of $3.3M.

Net loss attributable to stockholders was $4.3M for the quarter and $14.8M for the nine months, compared with $4.2M and $17.7M a year earlier. The company ended March 31, 2026 with cash and cash equivalents of $0.4M, total liabilities of $38.5M, and a stockholders’ deficit of $20.8M. Dalrada discloses negative working capital of $22.0M and states that recurring losses, cash burn, and reliance on debt and equity financing raise substantial doubt about its ability to continue as a going concern.

Rhea-AI Summary

Dalrada Technology Group reported continued losses and severe balance sheet weakness for the quarter ended December 31, 2025. Total revenue was $3.26 million, roughly flat versus the prior year’s $3.11 million, while six‑month revenue fell to $7.36 million from $9.15 million. Gross profit improved to $1.12 million in the quarter, but selling, general and administrative expenses of $4.70 million kept operations unprofitable, leading to a quarterly operating loss of $3.57 million and a six‑month net loss of $10.49 million.

The company’s financial position is strained. It ended the period with only $70,074 of cash and cash equivalents, total assets of $17.59 million, and total liabilities of $34.49 million, resulting in a stockholders’ deficit of $16.90 million. Management discloses negative working capital of $15.34 million and states there is “substantial doubt” about Dalrada’s ability to continue as a going concern without new financing and improved subsidiary performance.

Dalrada relies heavily on related‑party financing, with $8.58 million in related‑party payables and $4.64 million in related‑party notes payable, and has layered on multiple high‑cost loans and revenue purchase agreements. Operating cash outflows of $3.26 million in the first half of fiscal 2026 were covered only by $3.00 million of net cash from financing activities.